Oct 23, 2013
1:50
For every 50 shares held, investors received 1.
The split itself did not change the total investment value.
Aurinia Pharmaceuticals Inc (GETTEX:IKAP) operates in the Biotechnology industry.
Aurinia Pharmaceuticals Inc company overviewAurinia Pharmaceuticals Inc's most recent stock split was on October 23, 2013. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
Aurinia Pharmaceuticals Inc has split its stock once. This history records one reverse split, on October 23, 2013.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Aurinia Pharmaceuticals Inc's 1-for-50 reverse split on October 23, 2013, every 50 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Aurinia Pharmaceuticals Inc has not announced a new split in our records. Its most recent split was on October 23, 2013, 13 years ago. Companies announce splits in advance, and any new GETTEX:IKAP split will appear on this page.
Already premium?